baber/WOPTO huggingface dataset:
Patent PT-1171065-E (PT)
Title: Wound treatment apparatus employing reduced pressure
Inventor: HUNT KENNETH WILLIAM
IPC: A61M1/00
Filed: 2000-04-20
Abstract: Apparatus is described for stimulating healing of wounds, particularly burns, to the hands or feet. The apparatus comprises an envelope for receiving the affected part of the body. The envelope (12) comprises an air-tight cover which contains a porous pad (22, 24, 26) for covering the wound. Means are provided for connecting the interior of the envelope to a source of suction.
Patent PT-1451302-E (PT)
Title: In vitro reconstituted sheets of human corneal epithelium and method of producing the same
Inventor: LUCA MICHELE DE
IPC: A61K35/12
Filed: 2001-11-28
Abstract: A method of reconstructing laminae of human epithelium corneae in vitro to be used in grafts from cultures of limbar stem cells as well as a method of selecting and transferring such cells to fibrin substrate.
Patent PT-1272418-E (PT)
Title: Emergency power supply device for lift systems
Inventor: EILINGER THOMAS
IPC: B66B5/02
Filed: 2001-03-21
Abstract: Emergency current supply equipment for lift installations with electric motor drives has the task of bridging over temporary drops or interruptions in main voltage and of supplying, in the event of failure of the mains supply during a lift travel, all components of the lift installation needed for an evacuation travel with energy until such time as the lift car has reached the level of a story. The energy storage unit used for that purpose comprises as the storage medium exclusively capacitors in the form of super capacitors or a combination of super capacitors and electrochemically acting batteries.
Patent PT-1180074-E (PT)
Title: Motorcycle hub modular carrier rings
Inventor: MIYAKE FRANK T
IPC: B60B27/00
Filed: 2001-02-26
Abstract: A modular carrier ring for a motorcycle wheel hub assembly comprising a flat plate including a central flange forming a center bore therein for placement over the wheel hub, the central flange having a plurality of spaced-apart first through-holes formed therein for matching assembly with a like plurality of spaced-apart second through-holes formed in the wheel hub, the first through-holes and the second through-holes arranged for receipt therein of threaded fastening means to hold the flange tightly against the wheel hub, the central flange having a plurality of spaced-apart shallow apertures formed therein, in sequentially spaced arrangement with the first through-holes, for matching assembly with a like plurality of shallow apertures formed in the wheel hub for receipt therebetween of non-threaded anchor pins, a plurality of spaced-apart cross-arms extending outward from the central flange terminating in an anchor ring, and a plurality of tabs extending outward from the anchor ring each of the tab having formed therein a through hole for attachment to a wheel component of the motorcycle.
Patent PT-1255845-E (PT)
Title: Modified cytokines for use in cancer therapy
Inventor: CORTI ANGELO
IPC: C07K7/00
Filed: 2001-02-13
Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
Patent PT-1251750-E (PT)
Inventor: BORSCHEL MARLENE W
IPC: A23L29/10
Filed: 2001-01-16
Abstract: The present invention provides an improved pediatric formula and methods for providing nutrition to and enhancing tolerance in pediatric patients. The formula may be provided in powder, concentrate or ready-to-feed forms. The pediatric formula comprises, based on a 100 kcal basis, about 8 to about 16 grams carbohydrate (preferably about 9.4 to about 12.3 grams), about 3 to about 6 grams lipid (preferably about 4.7 to about 5.6 grams), about 1.8 to about 3.3 grams protein (preferably about 2.4 to about 3.3 grams), and a tolerance improver comprising a sufficient quantity for xanthum gum to produce a viscosity of no greater than about 200 centipoise at a pH of 4.0, or less. The formula may also be provided in a powder. The formula preferably further comprises vitamins and minerals and may further comprise a stabilizer. The methods comprise administering to a pediatric patient an effective amount of a pediatric formula according to the invention, as described above.
Patent PT-1310585-E (PT)
Title: Melting and spinning device and melting and spinning method
Inventor: SEKKEI KEIJI IGAKI
IPC: D01D1/06
Filed: 2002-04-15
Abstract: The present invention is relative to a melt spinning apparatus for melt spinning a biodegradable polymer material. The biodegradable polymer material is melted by a melt mechanism (4) including a screw (16) which is mounted in a vertically mounted cylinder (8) coaxially with the cylinder (8) and which is rotationally driven by a rotational driving mechanism (7). The screw includes at least one turn of a helical groove (17) on its peripheral surface. The biodegradable polymer material being melted in this way is discharged in the vertical direction from a discharge opening of a nozzle (10) mounted coaxially on the cylinder (8). <IMAGE>
Patent PT-1423115-E (PT)
Title: Antiangiogenic activity of nitrogen substituted thalidomide analogs
Inventor: SHAH JAMSHED H
IPC: A61P35/00
Filed: 2002-08-06
Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
Patent PT-1462370-E (PT)
Title: Unit for applying opening devices to packages of pourable food products
IPC: B65B61/18
Filed: 2003-03-28
Abstract: There is described a unit (1) for applying opening devices (2) to packages (3) of pourable food products having a pierceable portion (5), the unit substantially having conveying means (20) for feeding the packages (3) successively along a given path (P1); and gripping means (26) for receiving the opening devices (2) at a pickup station (11), and which move cyclically between the pickup station (11) and an application station (12) interfacing with the path (P1) and where the opening devices (2) are applied to respective packages (3); the trajectory of the gripping means (26) from the application station (12) to the pickup station (11) is distinct from the path (P1) of the packages (3); and the unit (1) also comprises pressure means (31) generating a contact pressure between the packages (3) and the opening devices (2) as of the application station (12) and along at least a portion (X) of the path (P1) of the packages (3). <IMAGE> <IMAGE>
Patent PT-1391215-E (PT)
Title: Automated infusion system with dose rate calculator
Inventor: DASTUR KAMAL M
IPC: G16H20/17
Filed: 1996-05-15
Abstract: This invention is a medical infusion system having an integrated dose rate calculation feature for selectively assigning values to a plurality of infusion parameters and automatically calculating an infusion rate from the selected parameters. <IMAGE>
Patent PT-1554428-E (PT)
Title: Belt with an integrated monitoring mechanism
Inventor: EICHHORN ROLAND
IPC: D07B1/14
Filed: 2003-10-10
Abstract: A belt has at least two fiber strands which have synthetic fiber threads twisted in themselves and are designed for acceptance of force in longitudinal direction. The strands are arranged at a spacing relative to one another along the longitudinal direction of the belt and are embedded in a belt casing. At least one of the strands comprises an electrically conductive indicator thread which is twisted together with the synthetic fiber threads of the strand, wherein the indicator thread is arranged outside the center of the fiber bundle. The indicator thread has a breaking elongation (epsilon<SUB>ult,Ind</SUB>) which is smaller than the breaking elongation (epsilon<SUB>ult,Trag</SUB>) of individual synthetic fiber threads of the strand. It can be electrically contacted so that an electrical monitoring of the integrity thereof is made possible.
Patent PT-1552777-E (PT)
Title: Piston for a beverage infusion automatic machine
Inventor: CARBONINI CARLO
IPC: A47J31/36
Filed: 2004-01-09
Abstract: A piston (11) of an automatic machine for infusion of beverages, such as coffee and the like, the piston having a piston head (13a, 13b) divided into two parts connected together and axially movable relative to each other, an annular gasket (15) being housed between those parts and radially expanding when an axially directed thrust such as to make said two piston parts (13a, 13b) approach each other is applied onto said piston (11), wherein the elastic resistance of said gasket (15) keeps said two piston parts (13a, 13b) spaced apart when no axial thrust is applied onto the piston. <IMAGE>
Patent PT-1618543-E (PT)
Title: Label for wet applications
Inventor: FRANKHUISEN JOHN
IPC: B32B27/10
Filed: 2004-02-18
Abstract: A label for a bottle where the label is comprised of a laminate where an outer layer (3) is a material susceptible to losing opaqueness when made wet, and an inner layer (5) behind this first layer which is a material that is opaque, and such that it will maintain such opaqueness when wet.
Patent PT-1631298-E (PT)
Title: Glycosaminoglycans for treating emotional dysfunctions
Inventor: CORNELLI UMBERTO
IPC: A61K31/715
Filed: 2004-05-19
Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (±200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
Patent PT-1910381-E (PT)
Title: Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs
Inventor: SUNDERMANN CORINNA
IPC: C07D498/10
Filed: 2006-06-27
Abstract: Substituted 1-oxo-3,8-diazospiro[4.5]-decan-2-one compounds (I) and their stereoisomers, enantiomers, racemates, salts or solvates, are new. Substituted 1-oxo-3,8-diazospiro[4.5]-decan-2-one compounds of formula (I) and their stereoisomers, enantiomers, racemates, salts or solvates are new. n : 1-5; R 1>6-10C aryl or 5-14C heteroaryl (both optionally substituted and the aryl and/or heteroaryl is condensed with optionally substituted mono- or bicyclic ring system); R 2>e.g. -C(=S)-NH-R 3>; and R 3>e.g. optionally substituted 1-10C aliphatic group. Full Definitions are given in the DEFINITIONS (Full Definitions) Field. An independent claim is included for the preparation of (I). [Image] ACTIVITY : Analgesic; Eating-Disorders-Gen.; Anabolic; Anorectic; Immunomodulator; Antimigraine; Antidepressant; Uropathic; Antitussive; Antiasthmatic; Ophthalmological; Antiinflammatory; Neuroprotective; Antiparkinsonian; Anticonvulsant; Nootropic; Dermatological; CNS-Gen.; Antidiarrheic; Gastrointestinal-Gen.; Antiulcer; Antipruritic; Tranquilizer; Neuroleptic; Relaxant; Antialcoholic; Antismoking; Cardiovascular-Gen.; Vasotropic. MECHANISM OF ACTION : 5-Hydroxy tryptamine uptake receptor inhibitor; Noradrenaline uptake receptor inhibitor The affinity of (I) to bind 5-hydroxytryptamine uptake receptor was tested using biological assays. The results showed that the binding inhibition of (I) was 84% at 10 mu M concentration.
Patent PT-1919637-E (PT)
Title: System and method for accelerating the conversion of asbestos in the process of mineralogical conversion
Inventor: TIMMONS DALE M
IPC: B09B3/00
Filed: 2006-06-30
Abstract: A process and equipment that accelerates the rate at which asbestos is converted into non-asbestos minerals during the process of mineralogical conversion, the process consisting of new methods and equipment for handling the asbestos that promotes absorption of mineralizing agents, increases the heat transfer properties of the asbestos, increases the overall efficiency of the process, and shortens the period of time required for processing.
Patent PT-2101906-E (PT)
Title: Method of replacing the catalyst tubes of a hydrocarbon reformer
Inventor: GALLARDA JEAN
IPC: B01J8/06
Filed: 2007-01-09
Abstract: A method for the maintenance of a furnace for the catalytic reforming of a hydrocarbon reaction mixture, equipped with tubes filled with catalyst and for which one portion of the tubes is provided with thermocouples, the method comprising a monitoring of the temperature of the tubes is provided.
Patent PT-2146450-E (PT)
Title: Method and apparatus for supervising a potentially gated signal in a wireless communication system
Inventor: OU YU-CHEUN
IPC: H04B7/005
Filed: 2000-06-22
Abstract: Apparatus and method for use in a mobile station in a wireless communication system, comprising in which: 
a decoder (218) detects if frames received from a base station are good or bad; 
a first counter (224) counts received bad frames; 
a second counter (226) counts received good frames; 
a control processor for resets the first counter (224) to zero and incrementing the second counter (226) by one if a received frame is declared a good frame, and incremens the first counter (224) by one and resetting the second counter (226) to zero if a received frame is declared a bad frame, and disables a transmitter if the value of the first counter (224) reaches a predetermined threshold.
Patent PT-748803-E (PT)
Inventor: KANOU FUMIHIKO
IPC: C07D333/34
Filed: 1995-12-25
Abstract: There is described a process for preparing 3-(2-thienylthio)butyric acid by converting a compound having the formula (III): <CHEM> wherein R is a straight chain or branched C1 to C4 alkyl group, whereby the production of 3-(3-thienylthio)butyric acid as a by-product which is the position isomer can be controlled to at most 0.1 mol %. 3-(2-Thienylthio)butyric acid is a useful compound as an intermediate for a medicinal compound.
Patent PT-732338-E (PT)
Inventor: WILDFEUER MARVIN EMANUEL
IPC: C07H15/04
Filed: 1996-01-09
Abstract: Ribose derivs. of formula (I) - (IV) are new. B = opt. protected pyrimidine nucleo-base; R = a hydroxy protecting gp.; R1, R2 = 1-8C alkyl or phenyl (both opt. substd.) or H; and R3 = 1-8C alkyl.
Patent PT-778277-E (PT)
Inventor: CHEN YUHPYNG L
IPC: A61P25/26
Filed: 1996-11-07
Abstract: Corticotropin-releasing factor (CRF) antagonists having the formula   <CHEM>     or <CHEM> wherein the dashed lines, A, B, D, E, F, Z, G, R<3>, and R<5> are as defined below, and pharmaceutical compositions containing them.
Patent PT-915222-E (PT)
Inventor: POUSSARD JEAN-CLAUDE
IPC: G01V15/00
Filed: 1998-10-01
Abstract: This invention relates to an antitheft collar for bottles, characterized in that it consists of two hinged half-rings that comprise additional removable locking means (12, 13) to ensure that the collar is locked around the neck of a bottle, whereby at least one (2) of half-rings (2, 3) comprises means (102, 142) for attaching a detectable device that is able to trigger a remote alarm, whereby the inside surface of each of the half-rings comprises a number of flanges (4) that are intended to come into contact and are deformed on the neck of the bottle when the collar is closed, whereby flanges (4) can be deformed so as to make it possible for the collar to fit bottle necks of various diameters.
Patent PT-911267-E (PT)
Inventor: MATHYS PHILIPPE
IPC: B65D5/54
Filed: 1998-10-23
Abstract: The corrugated cardboard carton comprises a container (2) and a fold down cover (3) with a closing flap (31). A double sided adhesive band for fastening the cover is stuck on one wall (22). The closing flap comprises a narrow strip, (32) arranged on the lateral edge of the adhesive band when the flap is closed, allowing the carton to be torn along the band.
Patent PT-1030667-E (PT)
Inventor: ANDREWS JOHN STUART
IPC: A61P25/00
Filed: 1998-11-13
Abstract: The compound mirtazapine is found to be effective in treating sleep apneas. Optionally, mirtazapine is combined with an SSRI such as fluoxetin.
Patent PT-965472-E (PT)
Inventor: DIETER HAHN
IPC: B60J10/74
Filed: 1999-06-10
Abstract: Automobile window glass includes a peripheral zone that cooperates at least in places with a sealing element (4). The surface of the glass (1), at least in the peripheral zone of contact with the sealing element (4), is provided with a structuring element (2) in order to establish a large number of locally limited contact surfaces between the sealing element and the glass (1). The structuring element (2) is made of sintered ceramic that is preferably transparent, and is obtained from a material applied by serigraphy. The element (2) comprises a number of points (3) or a line structure.
Patent SG-125092-G (SG)
Title: Bottle sealing cap for two component containers
IPC: B65D51/28
Filed: 1992-12-09
Abstract: 1. Bottle closure cap (1) for two-component packages, with a collar (7) which starts from the base of the pot-shaped cap, said cap having a thread (3) for screwing onto the bottle at the pot inner wall (2), and which, via a thread (10) running in the opposite direction to the thread for screwing onto the bottle, carries a cup (8) which can be brought into rotationally fixed but axially displaceable coupling engagement with the inner wall of the bottle neck via projections (12) situated on the outside of its cup circumferential wall, characterized in that the front end (7') of the collar (7) enters positively into an annular groove (14) at the base (15) of the cup (8).
Patent IE-870036-L (IE)
Title: Re-sintered cubic boron nitride
IPC: C04B35/58
Filed: 1987-01-07
Abstract: Disclosed is a method for making re-sintered polycrystalline CBN compact which comprises placing sintered boron-rich polycrystalline CBN particles in a high temperature/high pressure apparatus and subjecting said boron-rich CBN particles to a pressure and a temperature adequate to re-sinter said particles, the temperature being below the reconversion temperature of CBN, for a time sufficient to re-sinter the polycrystalline CBN particles therein. The boron-rich polycrystalline CBN particles in the HP/HT apparatus contain no impurity which would interfere with the sintering process (CBN sintering inhibiting impurities) and no sintering aid material.
Patent IE-32634-L (IE)
Title: Printing ink
IPC: C08L3/02
Filed: 1969-01-31
Abstract: 1,264,383. Anti-offset agents in printing inks. SALVAT EDITORES S.A., and COLORES Y DERIVADOS S.A. 13 Feb., 1969 [14 Feb.. 1968], No. 7976/69. Heading C4A. [Also in Division B6] Printing inks comprise as an anti-offsetting agent a non-aqueous organic fluid medium containing at least 10% by wt. of dispersed waterswellable starch granules, the organic fluid medium being compatible with the ink. The medium may be an animal, vegetable or mineral oil, or deca- or tetrahydronaphthalene, preferably a petroleum fraction distilling between 260‹ and 320‹ C.; castor, tung, linseed, cottonseed, olive and coconut oils, gasoline, heavy naphtha, white spirit and high petroleum fractions are disclosed. The agent may also include 0À25- 2% by wt. of an acid or acid salt, e.g. citric, malic, or meso or racemic tartaric acids. The starch granules may have an average diameter, when dry, of up to 30 microns. Up to 20% by weight anti-offset agent may be used in the ink, preferably about 3% of an agent containing 60-65% starch, so as to introduce 1À8% starch particles into the ink. The ink to which the agent is added may have a viscosity of 200- 1,100 poise at 20‹ C., and may be based on an oil or a phenolic varnish.
[GB1264383A]
Patent IE-43978-L (IE)
Title: Pharmaceutical composition; 1,3-dialkyl-7-oxoalkylxanthines
IPC: C07D473/06
Filed: 1976-01-30
Abstract: By reaction of a compound of the formula II <IMAGE> or a salt thereof with an agent introducing a radical of the formula -A-CO-CH3 (III> in particular by reaction of a compound of the formula II with a ketone of the formula CH2=CR-CO-CH3 (V> wherein in the above formulae the radicals R1, A and R have the meanings given in Patent Claims 1 and 4, the corresponding 7-substituted xanthine derivatives are obtained. During the reaction, the carbonyl group of the radical of the formula III or of the compound of the formula V is optionally intermediately protected. The novel compounds are useful medicaments for the treatment of disorders of the cardiovascular system, since they improve the circulation of the skeletal musculature and/or decrease or prevent arrhythmias.
[GB1496316A]
Patent IE-810265-L (IE)
Title: Indane derivatives
IPC: C07D211/14
Filed: 1981-02-12
Abstract: The invention provides compounds of formula <IMAGE> wherein R1 and R2 are alkyl, R3 is hydrogen, alkyl, alkenyl, phenylalkyl or a group -(CH2-CH2-O)n-R4 in which n is 1 to 3 and R4 is hydrogen or an acid residue, and the ring A is unsubstituted or substituted, with the proviso that when R3 is methyl the ring A is substituted. The compounds are useful in the treatment and prophylaxis of allergic conditions.
[US4351838A]
Patent IE-44520-L (IE)
Title: Variable hardness polyurethane moulded parts
IPC: C08J9/14
Filed: 1977-02-11
Abstract: A CONTlNUOUS PROCESS FOR PRODUCING VARIABLE HARDNESS POLYURETHANE MOLDED PARTS The instant invention generally relates to the continuous production of variable hardness molded polyurethane foam parts. Hardness of a foam is a function of the density of the foam and the index of the foamable reaction mixture. These variable hardness parts are continuously produced by the controlled addition of an inert blowing agent which directly affects density. These parts may also be produced by utilizing the double effect of controlling both the addition of the blowing agent and the foam index.
[CA1086915A]
Patent IE-32985-L (IE)
Title: Sulphanilamide derivatives
IPC: C07D235/30
Filed: 1969-03-13
Abstract: 1,263,561. Imidazolidine derivatives. J. R. GEIGY A.G. 14 March, 1969 [14 March, 1968 (2)], No. 13513/69. Heading C2C. Novel Compounds I (including salts thereof) wherein R 1 signifies alkyl or alkenyl of at most 5 carbons or an optionally alkyl-substituted cycloalkyl or cycloalkenyl group or a cycloalkyl-alkyl or cycloalkenyl-alkyl group of at most 7 carbons and R 2 is Me or Et, are obtained: (a) by reacting a Compound II (R 3 signifies H, Me, allyl, aryldiaryl- or triarylmethyl and X signifies NH 2 or a group which can be converted into NH 2 by hydrolysis, reduction or reductive cleavage) with a reactive cyanic acid derivative; (b) by reacting a Compound III with a nitrile, R 1 NH.CN or with an alkali or alkaline earth metal salt thereof; (c) by reducing a Compound V (R 1 <SP>1</SP> signifies C 3-5 alkenyl or C 5-7 cycloalkenyl); or (d) by reacting a functional derivative of a sulphonic acid VI with an imidazoline VII (also described as the hydrobromide) Compounds II, III and VII are in general prepared by standard methods. Intermediates to Compounds I, e.g. compounds wherein in place of NH 2 in I there is an MeCONH- group may be produced by methods (a) to (d). N - Tert. butyl - (2 - benzylamino) - propionamide (also described as the hydrochloride), obtained by the interaction of benzylamine and N - tert. - butyl - 2 - chloro - propionamide, reacts with lithium aluminium hydride to afford N<SP>1</SP>- tert.-butyl-N<SP>2</SP>-benzyl-1,2-propane-diamine; the diamine is debenzylated to give N<SP>1</SP>-tert.-butyl- 1,2 - propane - diamine dihydrobromide. The following related compounds are also described: N-butyl-2-benzylamino-propionamide and -butyramide, N<SP>1</SP>-butyl-N<SP>2</SP>-benzyl-1,2-propanediamine and -1,2-butanediamine,and N<SP>1</SP>-butyl-1,2-propane diamine and -1,2-butane-diamine. N-Butyl-andbenzyl-2-chloro-propionamides are obtained by reacting 2-chloro-propionyl chloride with butyl amine or benzylamine (N-butyl-2-chloro-butyramide is similarly obtained); N-benzyl-2-tert.- butylamino -propionamide, N<SP>1</SP>-benzyl-N<SP>2</SP>-tert.- butyl-1,2-propanediamine and N<SP>2</SP>-tert.-butyl-1,2- propane diamine hydrobromide are also described. Pharmaceutical preparations showing hypoglycaemic action contain I as active-ingredient; administration may be orally or parenterally.
[GB1263561A]